University College London Featured PhD Programmes
University College London Featured PhD Programmes
University of Southampton Featured PhD Programmes
University of Glasgow Featured PhD Programmes
Centre for Genomic Regulation (CRG) Featured PhD Programmes

Novel drug delivery systems for Schizophrenia treatment

  • Full or part time
  • Application Deadline
    Applications accepted all year round
  • Self-Funded PhD Students Only
    Self-Funded PhD Students Only

Project Description

This PhD project aims to develop, characterise and test a new type of implantable device to provide sustained antipsychotic drug delivery for schizophrenia treatment.
Schizophrenia is a chronic mental disorder affecting ca. 7 per 1000 adults globally. It requires long-term treatment with antipsychotic drugs. Patients with schizophrenia frequently discontinue treatment (up to 74% of them within the first 18 months). Non-adherence to treatment increases the risk of relapse, hospitalisation and suicide. Moreover, the economic burden of relapse can cost the NHS up to £15,000/year per patient. Therefore, the development of systems capable of providing unattended-prolonged drug delivery have potential to improve schizophrenia treatment.
The proposed devices will be implanted by a healthcare professional in a minimally-invasive way. Once in place, the implant will not generate discomfort or pain. They will be able to provide continuous unattended drug delivery for up to 6 months. These devices will be made of medical-grade bioresorbable polymers. Accordingly, they will be biodegraded after administering their drug cargo and do not require extraction. Importantly, drug administration the devices will be design to maximise drug concentration within the brain, while reducing the amount of drug in the systemic circulation. This will contribute significantly to reducing the drug doses required, while minimising the side effects of the treatment. Consequently, the proposed implants have potential to significantly improve the quality of life of schizophrenic patients.

Funding Notes

Applicants should have a 1st or 2.1 honours degree (or equivalent) in a relevant subject. Relevant subjects include Pharmacy, Molecular Biology, Pharmaceutical Sciences, Biochemistry, Biological/Biomedical Sciences, Chemistry, Engineering, or a closely related discipline. Students who have a 2.2 honours degree and a Master’s degree may also be considered, but the School reserves the right to shortlist for interview only those applicants who have demonstrated high academic attainment to date

How good is research at Queen’s University Belfast in Allied Health Professions, Dentistry, Nursing and Pharmacy?

FTE Category A staff submitted: 33.00

Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully

FindAPhD. Copyright 2005-2019
All rights reserved.